# SOFIE Co. dba SOFIE – FDA Inspection, Aug 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/f281f4bb-bf39-41b2-9fdc-c6b2cd5ab649
Source feed: FDA_Inspections

> FDA inspection 1280292 of SOFIE Co. dba SOFIE, August 28, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 212. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280292
- Company Name: SOFIE Co. dba SOFIE
- Inspection Date: 2025-08-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 966039 - 2016-03-18
- [FDA Inspection 882139 - 2014-06-06](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/0387d49b-728d-4937-ad47-164a9a8845a6)
- [FDA Inspection 794296 - 2012-08-16](https://www.keypedia.com/records/fda_inspections/sofie-co-dba-sofie/6bd0fc2f-488a-4d55-a1b2-044ff99899e8)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/david-a-oluwo/209d60bd-27d8-487b-8249-1c6e44fcc317)

Company: https://www.keypedia.com/companies/sofie-co-dba-sofie/c683c431-3e42-49e6-a2fa-20743b596202

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa